Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions, today announced the commercial availability of Evercode (TM) Whole ...
Rare cancers encompass a heterogeneous group of malignancies characterized by low incidence and prevalence but, often, disproportionately high mortality ...
This Research Topic is the second volume of the “Unraveling Breast Cancer Complexity: Insights from Single-Cell Sequencing and Spatial Transcriptomics” ...
(MEMPHIS, Tenn. – June 17, 2025) Single-cell RNA sequencing provides scientists with important information about gene expression in health and disease. However, the technique is expensive and often ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results